Innovative minimally invasive solution for patients & physicians dissatisfied with existing BPH and stricture options.
Portsmouth, NH
Joined November 2018
- Tweets482
- Following209
- Followers683
- Likes394
For men struggling with nocturia, urinary frequency, and incomplete emptying secondary to BPH, treatment options continue to evolve. Dr. Ali Kasraeian explores the role of Optilume BPH, a minimally invasive treatment designed to provide durable symptom relief while preserving patient quality of life.
September is National Prostate Health Month, an opportunity to encourage men experiencing LUTS secondary to BPH to seek evaluation earlier.
As patient expectations continue to evolve, many are looking for treatment options designed to provide symptom relief while minimizing disruption to their daily lives. How are you initiating BPH treatment discussions in your practice?
#BPH #Urology #MensHealth #ProstateHealthMonth
For men with recurrent urethral stricture disease, treatment fatigue is real.
Men’s Health Month is a reminder to reassess long-term management strategies and consider how minimally invasive innovations may fit into individualized care plans, especially for patients seeking alternatives to repeat procedures.
#MensHealthMonth #UrethralStricture #Urology #MensHealth
A new article highlights how the Optilume® Drug-Coated Balloon is helping transform care for patients with urethral stricture disease at Resolute Baptist Hospital in New Braunfels.
By combining mechanical dilation with localized drug delivery, Optilume offers a minimally invasive approach designed to provide durable relief from recurrent scar tissue.
We’re proud to see continued adoption of innovative solutions that help urologists improve outcomes and quality of life for their patients.
Read more: eu1.hubs.ly/H0wjSfv0
#Urology #MedTech #Innovation #PatientCare #Optilume #UrethralStricture
A common reason men delay BPH treatment? Fear of tradeoffs.
Concerns about invasiveness, recovery, or side effects often keep patients on medical therapy longer than they’d like or avoid treatment altogether. Men’s Health Month creates space to address these misconceptions and discuss the evolving range of minimally invasive options available today.
#MensHealthMonth #BPH #MinimallyInvasive #Urology
Many men reach a point where BPH medications no longer provide adequate relief, or were never a preferred long-term solution.
Men’s Health Month is a timely moment to reassess treatment pathways and discuss
next-step options that balance efficacy, durability, and patient experience.
#MensHealthMonth #BPHCare #Urology
Urethral stricture disease is common, recurrent, and often underrecognized despite its significant impact on quality of life.
Men’s Health Month is an opportunity to bring greater awareness to conditions that patients may struggle to articulate, especially after multiple prior interventions.
#MensHealthMonth #UrethralStricture #Urology #MensHealth
Medical innovation isn’t just about new technology. It’s about better experiences for patients.
As minimally invasive therapies continue to evolve, Men’s Health Month is a good moment to reflect on how innovation is shaping the future of urologic care.
You can learn more about the latest Optilume Drug Coated Balloon technologies here:
#MensHealthMonth #UrologyInnovation #MensHealth
Dr. Lucas Wiegand, a distinguished reconstruction urology at OrlandoHealth, shares his experience using Optilume as the first line of treatment for anterior urethral stricture disease. Because patients deserve the best option.
Watch his testimonial: eu1.hubs.ly/H0sqrxv0
Optilume’s drug coated balloon technology is changing the game for urethral stricture treatment for men. Dr. Meilika from the University of Rochester describes Optilume for urethral strictures as “straightforward, quick, and safe procedure.”
Learn more:eu1.hubs.ly/H0sqrKB0
Drug-coated balloon technology is changing the treatment of urethral stricture. Optilume® Stricture combines dilation and localized drug delivery for lasting results.
See how Brett is thriving after his Optilume procedure: eu1.hubs.ly/H0sqrGR0
Give your patients confidence in their stricture treatment plan this year. In the video below, Dr. Shakuri shares his positive experience with using Optilume in his practice.
Learn how this technology is changing the standard of care: eu1.hubs.ly/H0sqq_l0
Empower your patients in 2026. Optilume® BPH provides a proven, minimally invasive option for lasting relief. Learn more about clinical evidence: eu1.hubs.ly/H0rLJ8n0
#Optilume #BPH #Urology #PatientCare #InnovationInUrology #HealthFirst2026
The future of BPH treatment is here. Clinical studies show sustained symptom improvements up to 5 years (1). Discover why more urologists are choosing this minimally invasive option. Make 2026 the year of progress: eu1.hubs.ly/H0rLJ1T0
#Optilume #BPH #Urology #PatientCare #InnovationInUrology
ICYMI: Getting reimbursed is now easy as pie…or donuts. #OptilumeBPH has #CategoryI reimbursement! 🥧🍩
#BPH #urology #MIST #Laborie #MensHealth #AllAboutTheFlow #ProstateHealth
We’re proud to see Mount Sinai leading the way in advancing BPH care with innovative solutions like the Optilume® BPH Catheter System.
Read more about these advancements here: reports.mountsinai.org/artic…
#Optilume #BPH #UrologyInnovation
Mount Sinai is advancing the management of benign prostatic hyperplasia (BPH) through the adoption of innovative diagnostic tools, minimally invasive therapies, and technology-enabled care models designed to meet the diverse needs of an aging male population. By integrating new treatment platforms such as the Optilume® BPH Catheter System, next-generation robotic surgical technologies, and AI-driven disease management applications, Mount Sinai physicians are expanding therapeutic options while prioritizing safety, effectiveness, and quality of life. These coordinated efforts underscore the institution’s commitment to personalized, evidence-based urologic care and to delivering durable symptom relief through continual clinical innovation. Read more about these advancements here: mshs.co/4j6GT4F
Streamlined Category I reimbursement expands access to #OptilumeBPH for the more than 40 million men in the U.S. living with an enlarged prostate and the millions who pursue treatment for #BPH annually.
#urology #MIST #Laborie #MensHealth #AllAboutTheFlow #ProstateHealth
ICYMI: Our Category I announcement got its own Times Square billboard! Check out BTS footage from our trip to “The City That Never Sleeps” to 👀 the billboard IRL!
#BPH #urology #MIST #OptilumeBPH #Laborie #MensHealth #AllAboutTheFlow #ProstateHealth
Great @urologytimes roundup of its #Top10 #BPH articles in 2025. We spy an #optilumeBPH mention and @gpohlmanmd's post-@AmerUrologcal Annual Meeting
recap!
As the year comes to a close, take a look back at some of this year’s top content on benign prostatic hyperplasia. urologytimes.com/view/top-10…
🚨 ANNOUNCEMENT 🚨 #OptilumeBPH now officially has Category I reimbursement! Streamlined billing and coding – plus fewer headaches. All reasons to celebrate in a BIG way in the Big Apple! 🎉
#BPH #urology #MIST #Laborie #MensHealth #AllAboutTheFlow #ProstateHealth
